BONARTOS table. 1178 mg

Ingredients:

One tablet contains 1884,60 mg Glucosamine sulfate sodium chloride equivalent to 1500 mg Glucosamine sulfate and 1178 mg Glucosamine. Excipients: Core: Povidone K30, macrogol 4000, magnesium stearate, hypromellose, titanium dioxide E171, Talc, Coating: Propylene Glycol, Polysorbate 80.

Indications:

Symptomatic relief of mild to moderate osteoarthritis of the knee.

Dosage and administration:

Adults: One tablet daily. Glucosamine is not recommended for acute pain symptoms. Relief of symptoms (especially pain relief) is not expected before several weeks of treatment, and in some cases more. If you do not get no relief of symptoms after 2-3 months, the further application of glucosamine should be reconsidered. The tablets can be taken with or without food.

Elderly:

Clinical experience has shown that it is necessary to adjust the dose in healthy elderly. Children and adolescents: Bonartos not recommended for use in children and adolescents under the age of 18 due to lack of data on safety and efficacy.

Reduced renal and / or hepatic function:

No studies in this patient group.

Contraindications:

Bonartos should not be used in patients who are allergic to shell molluscs, since the active ingredient is an extract from the shells of molluscs, hypersensitivity to the active substance or to any of the excipients children under 2 years.

Interaction with other medicinal products and other forms of interaction:

Reported to enhance the effect of coumarin anticoagulants (eg, warfarin) when co-administered with glucosamine. Therefore, patients treated with coumarin anticoagulants should be monitored closely during the initiation and completion of treatment with glucosamine, glucosamine Concomitant use can increase the absorption and serum concentrations of tetracyclines, but the clinical significance of this interaction is probably limited, because insufficient data regarding potential interaction with glucosamine drugs should be considered a variation of the effect or concentration during concomitant use with other medicinal products.

Pregnancy and lactation:

Glucosamine should not be used during pregnancy. Not recommended the use of glucosamine by the mother during breastfeeding, because no data on the safety of the child.

Effects on ability to drive and use machines:

No studies on the effects of glucosamine on ability to drive and use machines. If signs of dizziness or drowsiness not recommend driving or operating machinery.

Packing:

1178 mg film-coated tablets of 30 and 90 pieces in HDPE containers with HDPE screw cap and 4, 10, 20, 30, 45, 60, 90 tablets in Alu / PVC / PVDC blisters. Not all pack sizes may be marketed.